NCT03190616 2020-01-14Apatinib in Refractory Colorectal CancerThe First Affiliated Hospital with Nanjing Medical UniversityPhase 2 Completed54 enrolled
NCT01531777 2015-04-03Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal CancerJiangsu HengRui Medicine Co., Ltd.Phase 2 Completed40 enrolled